Related Experiment Videos

Addressing oncologists' gaps in the use of biosimilar products

Chad Williamson, Leanne Berger, Thomas P Sullivan

The American Journal of Managed Care

|June 25, 2019

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis.

PharmacoEconomics - open·2026

Sex-based prognosis in industry-sponsored advanced solid tumor trials: an individual participant data meta-analysis of survival and adverse events.

Journal of the National Cancer Institute·2026

A budget impact model for biosimilar denosumab for skeletal-related events and fractures in the United States oncology population.

Journal of medical economics·2025

Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer.

Cancer medicine·2025

BLOC1S1 variants cause lysosomal and autophagic defects resulting in a hypomyelinating leukodystrophy with epileptic encephalopathy.

medRxiv : the preprint server for health sciences·2025

Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials.

International journal of cancer·2025

See all related articles